- All Products
- / Analytical Science
- / Drug Impurity Reference Substance
- / Anti-Tumor Drugs
- / Imatinib impurity
Imatinib impurity
Download Imatinib impurity Related Products
Imatinib (STI571) is an orally bioavailable tyrosine kinase inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR, and c-kit kinase activity. Imatinib (STI571) binds close to the ATP binding site, locking it in a closed or self-inhibited conformation, thereby semi-competitively inhibiting the enzymatic activity of the protein. Imatinib also inhibits SARS-CoV and MERS-CoV. ChemScene offers a range of Imatinib impurities to meet customer filing needs.
Imatinib impurity
download
Related products
In-stock:
Functional group:
Monofunctional group
Bifunctional group
Trifunctional group
Skeleton:
Inventory Status:
Chirality:
Purity:
Rule of 5:
-
In-stockPurity: ≥96%
Cat. No. : CS-0100406CAS No. : 581076-65-5* This product is not sold in the region.
-
In-stockPurity: ≥91%
Cat. No. : CS-0163897 -
In-stockPurity: ≥98%
Cat. No. : CS-0163914 -
In-stockPurity: ≥98%
Cat. No. : CS-0167020 -
In-stockPurity: ≥97%
Cat. No. : CS-0204134CAS No. : 152460-10-1* This product is not sold in the region.
-
In-stockPurity: ≥98%
Cat. No. : CS-0255276CAS No. : 571186-91-9* This product is not sold in the region.
-
In-stockPurity: ≥96%
Cat. No. : CS-0255282CAS No. : 1365802-18-1* This product is not sold in the region.
-
In-stockPurity: ≥98%
Cat. No. : CS-0255288CAS No. : 1407229-73-5* This product is not sold in the region.
-
In-stockPurity: ≥98%
Cat. No. : CS-4156 -
In-stockPurity: ≥97%
Cat. No. : CS-B1333